Ritonavir
5 NDCs across 5 manufacturers|4 Generic,1 Brand
Ritonavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 1, 1996, and the first generic was approved Jan 15, 2015. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $7 million on Ritonavir across 51,000 claims for 6,910 beneficiaries.
Ritonavir is available as 5 NDCs from 5 manufacturers (4 generic, 1 brand), with NADAC prices from $0.61 to $8.33 per EA — the most expensive product costs about 14× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
4G / 1B
Manufacturers
5
competing in market
Price Spread
$0.61 – $8.33
per EA
7d Activity
avg -2.5% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
5 manufacturers producing RITONAVIR(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NORVIR 100 MG TABLET | $8.3281 per EA | -0.13% |
RITONAVIR 100 MG TABLET | $1.7776 per EA | — |
RITONAVIR 100 MG TABLET | $0.6067 per EA | -3.26% |
RITONAVIR 100 MG TABLET | $0.6067 per EA | -3.26% |
RITONAVIR 100 MG TABLET | $0.6067 per EA | -3.26% |
Frequently Asked Questions
What is Ritonavir used to treat?
Ritonavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
When did Ritonavir become available as a generic?
FDA approved the first generic Ritonavir (ANDA) on Jan 15, 2015. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ritonavir?
In 2024, Medicare Part D spent $7 million on Ritonavir across 51,000 claims for 6,910 beneficiaries.
How many Ritonavir products are on the market?
The Ritonavir drug market contains 5 NDCs from 5 manufacturers — 4 generic and 1 brand product.
What is the price range for Ritonavir?
NADAC reference prices for Ritonavir range from $0.6067 to $8.3281 per EA — the most expensive product costs about 14× the cheapest.
Is generic Ritonavir cheaper than brand?
The average generic NADAC for Ritonavir is $0.8994 per EA, versus $8.3281 for brand-labeled products — brand versions average about 9.3× the generic price.
Which manufacturers make Ritonavir?
5 manufacturers list Ritonavir in NADAC. Ranked by number of NDCs, the largest are AbbVie Inc. (1), Amneal Pharmaceuticals LLC (1), Camber Pharmaceuticals Inc. (1), American Health Packaging (1), Aurobindo Pharma Limited (1).
How has the price of Ritonavir changed recently?
Over the past 7 days, 0 Ritonavir NDCs rose and 8 fell, with a market-wide average change of -2.5%.